Canopy Growth Corp (TSE:WEED - Get Free Report)'s share price shot up 6% on Monday . The company traded as high as C$5.92 and last traded at C$5.81. 1,546,871 shares traded hands during trading, a decline of 27% from the average session volume of 2,124,644 shares. The stock had previously closed at C$5.48.
Wall Street Analyst Weigh In
Separately, Canaccord Genuity Group lowered their price target on Canopy Growth from C$5.00 to C$3.50 and set a "sell" rating for the company in a report on Monday, August 12th.
View Our Latest Analysis on WEED
Canopy Growth Stock Performance
The company has a market capitalization of C$470.97 million, a PE ratio of -0.73, a P/E/G ratio of -0.01 and a beta of 1.79. The stock's 50-day simple moving average is C$6.15 and its 200 day simple moving average is C$8.57. The company has a debt-to-equity ratio of 117.00, a quick ratio of 2.32 and a current ratio of 2.15.
About Canopy Growth
(
Get Free Report)
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Further Reading
Before you consider Canopy Growth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.
While Canopy Growth currently has a "Strong Sell" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
